{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:39:35Z","timestamp":1790375975865,"version":"4.1.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11899-016-0353-y","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T01:13:55Z","timestamp":1482196435000},"page":"492-503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["T-cell Lymphoma Epidemiology: the Known and Unknown"],"prefix":"10.1007","volume":"11","author":[{"given":"Anh","family":"Phan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Veldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jo","family":"Lechowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,20]]},"reference":[{"key":"353_CR1","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program. National Cancer Instutite, DCCPS, Cancer Statistics Branch 2013; Available from: www.seer.cancer.gov [updated based on the November 2013 submission]."},{"issue":"8","key":"353_CR2","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/1097-0142(19821015)50:8<1539::AID-CNCR2820500814>3.0.CO;2-G","volume":"50","author":"J Whang-Peng","year":"1982","unstructured":"Whang-Peng J, Bunn Jr PA, Knutsen T, Matthews MJ, Schechter G, et al. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer. 1982;50(8):1539\u201353.","journal-title":"Cancer"},{"issue":"4","key":"353_CR3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/ajcp\/72.4.540","volume":"72","author":"GS Pinkus","year":"1979","unstructured":"Pinkus GS, Said JW, Hargreaves H. Malignant lymphoma, T-cell type A distinct morphologic variant with large multilobated nuclei, with a report of four cases. Am J Clin Pathol. 1979;72(4):540\u201350.","journal-title":"Am J Clin Pathol"},{"key":"353_CR4","doi-asserted-by":"crossref","unstructured":"Wang SS, Vose JM. Epidemiology and Prognosis of T-Cell Lymphoma. In: Foss, F, editor. T-cell Lymphomas. Humana Press; 2013. p. 25\u201339, Totowa, NJ: Humana Press","DOI":"10.1007\/978-1-62703-170-7_2"},{"issue":"11","key":"353_CR5","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"The NHL Classification Project","year":"1997","unstructured":"The NHL Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project. Blood. 1997;89(11):3909\u201318.","journal-title":"Blood"},{"key":"353_CR6","unstructured":"Lymphoma.org- http:\/\/www.lymphoma.org\/site\/pp.asp?c=bkLTKaOQLmK8E&b=6300161 ."},{"key":"353_CR7","unstructured":"Geskin Larisa J. Chapter 105. Cutaneous T-cell lymphoma (mycosis fungoides and S\u00e9zary syndrome). In: Lichtman MA, Kipps TJ, Seligsohn U, editors. Williams Hematology. 8th ed. Available from: AccessMedicine. Accessed 1 Aug 2016."},{"issue":"20","key":"353_CR8","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390. Highlighted the changes made in the updated 2016 World Health Organization (WHO) classification of lymphoid neoplasm, in terms of categorize of subtypes and clinical expectations.","journal-title":"Blood"},{"issue":"25","key":"353_CR9","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J et al. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124\u201330.","journal-title":"J Clin Oncol"},{"issue":"48","key":"353_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jncimonographs\/lgu005","volume":"2014","author":"LM Morton","year":"2014","unstructured":"Morton LM et al. Rationale and design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014;2014(48):1\u201314.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"353_CR11","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","volume":"15","author":"KJ Savage","year":"2004","unstructured":"Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol. 2004;15:1467\u201375. doi: 10.1093\/annonc\/mdh392 .","journal-title":"Ann Oncol"},{"issue":"11","key":"353_CR12","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1093\/annonc\/mdu443","volume":"25","author":"JS Abramson","year":"2014","unstructured":"Abramson JS et al. Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy. Ann Oncol. 2014;25(11):2211\u20137.","journal-title":"Ann Oncol"},{"issue":"9","key":"353_CR13","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/bjc.2015.94","volume":"112","author":"A Smith","year":"2015","unstructured":"Smith A et al. Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK\u2019s Haematological Malignancy Research Network. Br J Cancer. 2015;112(9):1575\u201384.","journal-title":"Br J Cancer"},{"issue":"9","key":"353_CR14","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2015.63.5540","volume":"34","author":"SV Adams","year":"2016","unstructured":"Adams SV et al. Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States. J Clin Oncol. 2016;34(9):963\u201371. Using SEER data from 2000-2012, this study examine the latest trends for each subtypes, in terms of age of diagnosis, survival rates, incidences rates, and case-case odd ratios by each.","journal-title":"J Clin Oncol"},{"issue":"48","key":"353_CR15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/jncimonographs\/lgu012","volume":"2014","author":"SS Wang","year":"2014","unstructured":"Wang SS et al. Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014;2014(48):66\u201375.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"3","key":"353_CR16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11899-015-0267-0","volume":"10","author":"JL Koff","year":"2015","unstructured":"Koff JL et al. To each its own: linking the biology and epidemiology of NHL subtypes. Curr Hematol Malig Rep. 2015;10(3):244\u201355.","journal-title":"Curr Hematol Malig Rep"},{"issue":"3","key":"353_CR17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12185-014-1520-3","volume":"99","author":"S Park","year":"2014","unstructured":"Park S, Ko YH. Peripheral T cell lymphoma in Asia. Int J Hematol. 2014;99(3):227\u201339.","journal-title":"Int J Hematol"},{"issue":"5","key":"353_CR18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2141.2011.08982.x","volume":"156","author":"WZ Ai","year":"2012","unstructured":"Ai WZ et al. Racial patterns of extranodal natural killer\/T-cell lymphoma, nasal type, in California: a population-based study. Br J Haematol. 2012;156(5):626\u201332.","journal-title":"Br J Haematol"},{"issue":"2","key":"353_CR19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00277-015-2543-4","volume":"95","author":"AM Perry","year":"2016","unstructured":"Perry AM et al. Non-Hodgkin lymphoma in the Far East: review of 730 cases from the International Non-Hodgkin Lymphoma Classification Project. Ann Hematol. 2016;95(2):245\u201351.","journal-title":"Ann Hematol"},{"issue":"2","key":"353_CR20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/annonc\/mdi037","volume":"16","author":"WY Au","year":"2005","unstructured":"Au WY et al. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Ann Oncol. 2005;16(2):206\u201314.","journal-title":"Ann Oncol"},{"issue":"1","key":"353_CR21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0609.2007.00978.x","volume":"80","author":"ST Lim","year":"2008","unstructured":"Lim ST et al. Comparative analysis of extra-nodal NK\/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis. Eur J Haematol. 2008;80(1):55\u201360.","journal-title":"Eur J Haematol"},{"key":"353_CR22","doi-asserted-by":"crossref","first-page":"624040","DOI":"10.1155\/2010\/624040","volume":"2010","author":"T Tang","year":"2010","unstructured":"Tang T et al. Peripheral T-cell lymphoma: review and updates of current management strategies. Adv Hematol. 2010;2010:624040.","journal-title":"Adv Hematol"},{"issue":"5","key":"353_CR23","doi-asserted-by":"crossref","first-page":"E432","DOI":"10.1002\/ijc.29237","volume":"136","author":"EK Cahoon","year":"2015","unstructured":"Cahoon EK et al. Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groups. Int J Cancer. 2015;136(5):E432\u201341.","journal-title":"Int J Cancer"},{"issue":"1","key":"353_CR24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/10428194.2015.1045897","volume":"57","author":"BE Beltran","year":"2016","unstructured":"Beltran BE et al. The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leuk Lymphoma. 2016;57(1):58\u201362.","journal-title":"Leuk Lymphoma"},{"key":"353_CR25","doi-asserted-by":"crossref","unstructured":"de Leval L et al. Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets. Haematologica. 2015;100(9):e361\u20134.","DOI":"10.3324\/haematol.2015.126300"},{"issue":"2","key":"353_CR26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2559.1993.tb00093.x","volume":"22","author":"G Khan","year":"1993","unstructured":"Khan G et al. Epstein-Barr virus in angioimmunoblastic T-cell lymphomas. Histopathology. 1993;22(2):145\u20139.","journal-title":"Histopathology"},{"issue":"2","key":"353_CR27","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.4081\/hr.2015.5893","volume":"7","author":"T Beer","year":"2015","unstructured":"Beer T, Dorion P. Angioimmunoblastic T-cell lymphoma presenting with an acute serologic Epstein-Barr virus profile. Hematol Rep. 2015;7(2):5893.","journal-title":"Hematol Rep"},{"issue":"10","key":"353_CR28","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","volume":"25","author":"M Fallah","year":"2014","unstructured":"Fallah M et al. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol. 2014;25(10):2025\u201330.","journal-title":"Ann Oncol"},{"issue":"4","key":"353_CR29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1309\/AJCP83AOQTMLOJTM","volume":"139","author":"L Quintanilla-Martinez","year":"2013","unstructured":"Quintanilla-Martinez L, Jansen PM, Kinney MC, Swerdlow SH, Willemze R. Non-mycosis fungoides cutaneous T-cell lymphomas: report of the 2011 Society for Hematopathology\/European Association for Haematopathology workshop. Am J Clin Pathol. 2013;139(4):491\u2013514.","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"353_CR30","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768\u201385.","journal-title":"Blood"},{"issue":"7","key":"353_CR31","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","volume":"119","author":"MF Benner","year":"2012","unstructured":"Benner MF, Jansen PM, Vermeer MH, Willemze R. Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases. Blood. 2012;119(7):1643\u20139.","journal-title":"Blood"},{"issue":"2","key":"353_CR32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/DAD.0b013e318289b1db","volume":"36","author":"W Kempf","year":"2014","unstructured":"Kempf W, Kazakov DV, Kerl K. Cutaneous lymphomas: an update. Part 1: T-cell and natural killer\/t-cell lymphomas and related conditions. Am J Dermatopathol. 2014;36(2):105\u201323.","journal-title":"Am J Dermatopathol"},{"issue":"9","key":"353_CR33","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/PAS.0b013e3181648d6d","volume":"32","author":"ME Kadin","year":"2008","unstructured":"Kadin ME, Pinkus JL, Pinkus GS, Duran IH, Fuller CE, et al. Primary cutaneous ALCL with phosphorylated\/activated cytoplasmic ALK and novel phenotype: EMA\/MUC1+, cutaneous lymphocyte antigen negative. Am J Surg Pathol. 2008;32(9):1421\u20136.","journal-title":"Am J Surg Pathol"},{"issue":"13","key":"353_CR34","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1158\/1078-0432.CCR-14-2195","volume":"21","author":"LR Baaij de","year":"2015","unstructured":"de Baaij LR et al. A new and validated clinical prognostic model (EPI) for enteropathy-associated T-cell lymphoma. Clin Cancer Res. 2015;21(13):3013\u20139. A respective study showed that the current prognostic model, IPI, to identify high risk patients with enteropathy-associated T-cell lymphoma can be improved by including B-symptoms.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"353_CR35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.0303-6987.2005.00495.x","volume":"32","author":"G Burg","year":"2005","unstructured":"Burg G et al. WHO\/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol. 2005;32(10):647\u201374.","journal-title":"J Cutan Pathol"},{"issue":"11","key":"353_CR36","first-page":"1372","volume":"89","author":"M Paulli","year":"2004","unstructured":"Paulli M, Berti E. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts II. Haematologica. 2004;89(11):1372\u201388.","journal-title":"Haematologica"},{"issue":"12","key":"353_CR37","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/jclinpath-2015-203133","volume":"68","author":"KG Sidiropoulos","year":"2015","unstructured":"Sidiropoulos KG, Martinez-Escala ME, Yelamos O, Guitart J, Sidiropoulos M. Primary cutaneous T-cell lymphomas: a review. J Clin Pathol. 2015;68(12):1003\u201310.","journal-title":"J Clin Pathol"},{"issue":"7","key":"353_CR38","first-page":"1","volume":"16","author":"N Yoshida","year":"2015","unstructured":"Yoshida N, Chihara D. Incidence of adult T-cell leukemia\/lymphoma in nonendemic areas. Curr Treat Options in Oncol. 2015;16(7):1\u20138.","journal-title":"Curr Treat Options in Oncol"},{"issue":"39","key":"353_CR39","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"FA Proietti","year":"2005","unstructured":"Proietti FA et al. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058\u201368.","journal-title":"Oncogene"},{"issue":"1","key":"353_CR40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1346-8138.12299","volume":"41","author":"T Hamada","year":"2014","unstructured":"Hamada T, Iwatsuki K. Cutaneous lymphoma in Japan: a nationwide study of 1733 patients. J Dermatol. 2014;41(1):3\u201310.","journal-title":"J Dermatol"},{"issue":"12","key":"353_CR41","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2169\/internalmedicine.54.1953","volume":"54","author":"N Kawano","year":"2015","unstructured":"Kawano N et al. Clinical features and treatment outcomes of 81 patients with aggressive type adult T-cell leukemia-lymphoma at a single institution over a 7-year period (2006-2012). Intern Med. 2015;54(12):1489\u201398.","journal-title":"Intern Med"},{"issue":"Suppl 1","key":"353_CR42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000431058","volume":"89","author":"K Ohshima","year":"2015","unstructured":"Ohshima K. Molecular pathology of adult T-cell leukemia\/lymphoma. Oncology. 2015;89 Suppl 1:7\u201315.","journal-title":"Oncology"},{"key":"353_CR43","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fmicb.2012.00322","volume":"3","author":"M Iwanaga","year":"2012","unstructured":"Iwanaga M, Watanabe T, Yamaguchi K. Adult T-cell leukemia: a review of epidemiological evidence. Front Microbiol. 2012;3:322.","journal-title":"Front Microbiol"},{"issue":"2","key":"353_CR44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5114\/pjp.2015.53013","volume":"66","author":"S Karaarslan","year":"2015","unstructured":"Karaarslan S, Hekimgil M, Soydan S, Ertan Y, Doganavargil B. Evaluation of the role of Epstein-Barr virus in cases of nodal or extranodal T- and NK-cell lymphoma using eber in situ hybridization. Pol J Pathol. 2015;66(2):161\u20139. doi: 10.5114\/pjp.2015.53013 .","journal-title":"Pol J Pathol"},{"issue":"2","key":"353_CR45","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/bjc.2012.566","volume":"108","author":"Q Cai","year":"2013","unstructured":"Cai Q et al. Fasting blood glucose is a novel prognostic indicator for extranodal natural killer\/T-cell lymphoma, nasal type. Br J Cancer. 2013;108(2):380\u20136.","journal-title":"Br J Cancer"},{"issue":"3","key":"353_CR46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/ejh.12439","volume":"94","author":"M Foppoli","year":"2015","unstructured":"Foppoli M, Ferreri AJ. Gamma-delta t-cell lymphomas. Eur J Haematol. 2015;94(3):206\u201318.","journal-title":"Eur J Haematol"},{"key":"353_CR47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13671-012-0038-2","volume":"2","author":"S Samimi","year":"2013","unstructured":"Samimi S. Update on epidemiology of cutaneous T-cell lymphoma. Curr Dermatol Rep. 2013;2:35\u201341.","journal-title":"Curr Dermatol Rep"},{"issue":"21","key":"353_CR48","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","volume":"113","author":"PT Bradford","year":"2009","unstructured":"Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113(21):5064\u201373.","journal-title":"Blood"},{"issue":"11","key":"353_CR49","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamadermatol.2013.5526","volume":"149","author":"K Korgavkar","year":"2013","unstructured":"Korgavkar K, Xiong M, Weinstock M. Changing incidence trends of cutaneous T-cell lymphoma. JAMA Dermatol. 2013;149(11):1295\u20139.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"353_CR50","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3109\/10428194.2012.729831","volume":"54","author":"MH Imam","year":"2013","unstructured":"Imam MH, Shenoy PJ, Flowers CR, Phillips A, Lechowicz MJ. Incidence and survival patterns of cutaneous T-cell lymphomas in the United States. Leuk Lymphoma. 2013;54(4):752\u20139.","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"353_CR51","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","volume":"143","author":"VD Criscione","year":"2007","unstructured":"Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol. 2007;143(7):854\u20139.","journal-title":"Arch Dermatol"},{"issue":"12","key":"353_CR52","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/cncr.29301","volume":"121","author":"IV Litvinov","year":"2015","unstructured":"Litvinov IV, Tetzlaff MT, Rahme E, Habel Y, Risser DR, et al. Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registries. Cancer. 2015;121(12):1993\u20132003.","journal-title":"Cancer"},{"issue":"9","key":"353_CR53","first-page":"595","volume":"122","author":"M Dupin","year":"1995","unstructured":"Dupin M, Darie H, Jumbou O, Veran Y, Gros P, et al. Conjugal mycosis fungoides. Ann Dermatol Venereol. 1995;122(9):595\u20138.","journal-title":"Ann Dermatol Venereol"},{"issue":"5 Suppl","key":"353_CR54","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1016\/j.jaad.2005.09.013","volume":"54","author":"AN Schmidt","year":"2006","unstructured":"Schmidt AN, Robbins JB, Greer JP, Zic JA. Conjugal transformed mycosis fungoides: the unknown role of viral infection and environmental exposures in the development of cutaneous T-cell lymphoma. J Am Acad Dermatol. 2006;54(5 Suppl):S202\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"353_CR55","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jaad.2006.09.016","volume":"56","author":"A Lozano","year":"2007","unstructured":"Lozano A, Duvic M. Cutaneous T-cell lymphoma in non-blood-related family members: report of an additional case. J Am Acad Dermatol. 2007;56(3):521.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"353_CR56","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.3816\/CLML.2010.s.010","volume":"10","author":"E Hodak","year":"2010","unstructured":"Hodak E, Friedman E. Familial mycosis fungoides: model of genetic susceptibility. Clin Lymphoma Myeloma Leuk. 2010;10 Suppl 2:S67\u20139.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"353_CR57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000077322","volume":"208","author":"P Weder","year":"2004","unstructured":"Weder P, Anliker M, Itin P, Bargetzi M. Familial cutaneous mycosis fungoides: successful treatment with a combination of gemcitabine and alemtuzumab. Dermatology. 2004;208(3):281\u20133.","journal-title":"Dermatology"},{"issue":"5","key":"353_CR58","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archdermatol.2010.60","volume":"146","author":"RG Pomerantz","year":"2010","unstructured":"Pomerantz RG, Campbell LS, Jukic DM, Geskin LJ. Posttransplant cutaneous T-cell lymphoma: case reports and review of the association of calcineurin inhibitor use with posttransplant lymphoproliferative disease risk. Arch Dermatol. 2010;146(5):513\u20136.","journal-title":"Arch Dermatol"},{"issue":"2","key":"353_CR59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaad.2004.11.060","volume":"54","author":"K Wilkins","year":"2006","unstructured":"Wilkins K, Turner R, Dolev JC, LeBoit PE, Berger TG, et al. Cutaneous malignancy and human immunodeficiency virus disease. J Am Acad Dermatol. 2006;54(2):189\u2013206. quiz 207-10.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"353_CR60","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00126334-200104010-00015","volume":"26","author":"RJ Biggar","year":"2001","unstructured":"Biggar RJ, Engels EA, Frisch M, Goedert JJ. Risk of T-cell lymphomas in persons with AIDS. J Acquir Immune Defic Syndr. 2001;26(4):371\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"353_CR61","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/1523-1747.ep12363352","volume":"107","author":"CM Jackow","year":"1996","unstructured":"Jackow CM, McHam JB, Friss A, Alvear J, Reveille JR, et al. HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma. J Invest Dermatol. 1996;107(3):373\u20136.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"353_CR62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/1523-1747.ep12553615","volume":"80","author":"B Safai","year":"1983","unstructured":"Safai B, Myskowski PL, Dupont B, Pollack MS. Association of HLA-DR5 with mycosis fungoides. J Invest Dermatol. 1983;80(5):395\u20137.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"353_CR63","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.clindermatol.2013.01.009","volume":"31","author":"JJ Mirvish","year":"2013","unstructured":"Mirvish JJ, Pomerantz RG, Falo Jr LD, Geskin LJ. Role of infectious agents in cutaneous T-cell lymphoma: facts and controversies. Clin Dermatol. 2013;31(4):423\u201331.","journal-title":"Clin Dermatol"},{"issue":"3","key":"353_CR64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/1523-1747.ep12363010","volume":"107","author":"GS Wood","year":"1996","unstructured":"Wood GS, Salvekar A, Schaffer J, Crooks CF, Henghold W, et al. Evidence against a role for human T-cell lymphotrophic virus type I (HTLV-I) in the pathogenesis of American cutaneous T-cell lymphoma. J Invest Dermatol. 1996;107(3):301\u20137.","journal-title":"J Invest Dermatol"},{"issue":"5100","key":"353_CR65","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1126\/science.8451646","volume":"259","author":"A Bazarbachi","year":"1993","unstructured":"Bazarbachi A, Saal F, Laroche L, Flageul B, P\u00e9ri\u00e8s J, et al. HTLV-1 provirus and mycosis fungoides. Science. 1993;259(5100):1470\u20131.","journal-title":"Science"},{"issue":"10","key":"353_CR66","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1038\/jid.2009.123","volume":"129","author":"V Courgnaud","year":"2009","unstructured":"Courgnaud V, Duthanh A, Guillot B, Sitbon M, Dereure O. Absence of HTLV-related sequences in skin lesions and peripheral blood of cutaneous T-cell lymphomas. J Invest Dermatol. 2009;129(10):2520\u20132.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"353_CR67","doi-asserted-by":"crossref","first-page":"205.e1-16","DOI":"10.1016\/j.jaad.2013.07.049","volume":"70","author":"SI Jawed","year":"2014","unstructured":"Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and S\u00e9zary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014;70(2):205.e1-16. quiz 221-2.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"353_CR68","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1182\/blood.V80.6.1537.1537","volume":"80","author":"D Zucker-Franklin","year":"1992","unstructured":"Zucker-Franklin D, Hooper WC, Evatt BL. Human lymphotropic retroviruses associated with mycosis fungoides: evidence that human T-cell lymphotropic virus type II (HTLV-II) as well as HTLV-I may play a role in the disease. Blood. 1992;80(6):1537\u201345.","journal-title":"Blood"},{"issue":"2","key":"353_CR69","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1172\/JCI117697","volume":"95","author":"BA Pancake","year":"1995","unstructured":"Pancake BA, Zucker-Franklin D, Coutavas EE. The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients. J Clin Invest. 1995;95(2):547\u201354.","journal-title":"J Clin Invest"},{"issue":"2","key":"353_CR70","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2133.1991.tb00434.x","volume":"124","author":"M Detmar","year":"1991","unstructured":"Detmar M, Pauli G, Anagnostopoulos I, Wunderlich U, Herbst H, et al. A case of classical mycosis fungoides associated with human T-cell lymphotropic virus type I. Br J Dermatol. 1991;124(2):198\u2013202.","journal-title":"Br J Dermatol"},{"issue":"5","key":"353_CR71","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.clindermatol.2015.05.008","volume":"33","author":"G Burg","year":"2015","unstructured":"Burg G. Systemic involvement in mycosis fungoides. Clin Dermatol. 2015;33(5):563\u201371.","journal-title":"Clin Dermatol"},{"issue":"5","key":"353_CR72","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","volume":"116","author":"JJ Campbell","year":"2010","unstructured":"Campbell JJ, Clark RA, Watanabe R, Kupper TS. Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood. 2010;116(5):767\u201371.","journal-title":"Blood"},{"issue":"2","key":"353_CR73","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2141.2011.08852.x","volume":"155","author":"HK Wong","year":"2011","unstructured":"Wong HK, Mishra A, Hake T, Porcu P. Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). Br J Haematol. 2011;155(2):150\u201366.","journal-title":"Br J Haematol"},{"issue":"6","key":"353_CR74","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/bjd.12909","volume":"170","author":"JJ Scarisbrick","year":"2014","unstructured":"Scarisbrick JJ, Kim YH, Whittaker SJ, Wood GS, Vermeer MH, et al. Prognostic factors, prognostic indices and staging in mycosis fungoides and S\u00e9zary syndrome: where are we now? Br J Dermatol. 2014;170(6):1226\u201336.","journal-title":"Br J Dermatol"},{"issue":"2","key":"353_CR75","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaad.2008.09.063","volume":"60","author":"G Sun","year":"2009","unstructured":"Sun G, Berthelot C, Li Y, Glass 2nd DA, George D, et al. Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides. J Am Acad Dermatol. 2009;60(2):231\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"353_CR76","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clml.2012.06.010","volume":"12","author":"LD Wilson","year":"2012","unstructured":"Wilson LD, Hinds GA, Yu JB. Age, race, sex, stage, and incidence of cutaneous lymphoma. Clin Lymphoma Myeloma Leuk. 2012;12(5):291\u20136.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"12","key":"353_CR77","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1365-4632.2010.04567.x","volume":"49","author":"QA Alsaleh","year":"2010","unstructured":"Alsaleh QA, Nanda A, Al-Ajmi H, Al-Sabah H, Elkashlan M, et al. Clinicoepidemiological features of mycosis fungoides in Kuwait, 1991-2006. Int J Dermatol. 2010;49(12):1393\u20138.","journal-title":"Int J Dermatol"},{"issue":"4","key":"353_CR78","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-0960.2006.00290.x","volume":"47","author":"ES Tan","year":"2006","unstructured":"Tan ES, Tang MB, Tan SH. Retrospective 5-year review of 131 patients with mycosis fungoides and S\u00e9zary syndrome seen at the National Skin Centre, Singapore. Australas J Dermatol. 2006;47(4):248\u201352.","journal-title":"Australas J Dermatol"},{"issue":"3","key":"353_CR79","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0959-8049(00)00383-X","volume":"37","author":"MM Morales Su\u00c3\u00a1rez-Varela","year":"2001","unstructured":"Morales Su\u00c3\u00a1rez-Varela MM, Olsen J, Kaerlev L, Gu\u00c3\u00a9nel P, Arveux P, et al. Are alcohol intake and smoking associated with mycosis fungoides? A European multicentre case-control study. Eur J Cancer. 2001;37(3):392\u20137.","journal-title":"Eur J Cancer"},{"issue":"8","key":"353_CR80","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/1346-8138.12202","volume":"40","author":"MS Jang","year":"2013","unstructured":"Jang MS, Jang JG, Han SH, Park JB, Kang DY, et al. Clinicopathological features of mycosis fungoides in patients exposed to Agent Orange during the Vietnam War. J Dermatol. 2013;40(8):606\u201312.","journal-title":"J Dermatol"},{"issue":"1","key":"353_CR81","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.yexmp.2010.05.001","volume":"89","author":"S Bonin","year":"2010","unstructured":"Bonin S, Tothova SM, Barbazza R, Brunetti D, Stanta G, Trevisan G. Evidence of multiple infectious agents in mycosis fungoides lesions. Exp Mol Pathol. 2010;89(1):46\u201350. doi: 10.1016\/j.yexmp.2010.05.001 .","journal-title":"Exp Mol Pathol"},{"issue":"48","key":"353_CR82","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/jncimonographs\/lgu008","volume":"2014","author":"B Aschebrook-Kilfoy","year":"2014","unstructured":"Aschebrook-Kilfoy B, Cocco P, La Vecchia C, Chang ET, Vajdic CM, et al. Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and S\u00e9zary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014;2014(48):98\u2013105.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1","key":"353_CR83","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000438669","volume":"232","author":"P Fava","year":"2016","unstructured":"Fava P, Bergallo M, Astrua C, Brizio M, Galliano I, et al. Human endogenous retrovirus expression in primary cutaneous T-cell lymphomas. Dermatology. 2016;232(1):38\u201343.","journal-title":"Dermatology"},{"issue":"4","key":"353_CR84","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/cncr.27740","volume":"119","author":"RR Jahan-Tigh","year":"2013","unstructured":"Jahan-Tigh RR, Huen AO, Lee GL, Pozadzides JV, Liu P, et al. Hydrochlorothiazide and cutaneous T cell lymphoma: prospective analysis and case series. Cancer. 2013;119(4):825\u201331.","journal-title":"Cancer"},{"key":"353_CR85","doi-asserted-by":"crossref","unstructured":"Van Santen S, Roach RE, van Doorn R, Horv\u00e1th B, Bruijn MS, et al. Clinical staging and prognostic factors in folliculotropic mycosis fungoides. JAMA Dermatol. 2016;152(9):992\u20131000.","DOI":"10.1001\/jamadermatol.2016.1597"},{"issue":"4","key":"353_CR86","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archderm.136.4.504","volume":"136","author":"R Doorn Van","year":"2000","unstructured":"Van Doorn R, Van Haselen CW, van Voorst Vader PC, Geerts ML, Heule F, et al. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol. 2000;136(4):504\u201310.","journal-title":"Arch Dermatol"},{"issue":"13","key":"353_CR87","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.ejca.2013.04.018","volume":"49","author":"EC Benton","year":"2013","unstructured":"Benton EC, Crichton S, Talpur R, Agar NS, Fields PA, et al. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome. Eur J Cancer. 2013;49(13):2859\u201368.","journal-title":"Eur J Cancer"},{"issue":"31","key":"353_CR88","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","volume":"28","author":"NS Agar","year":"2010","unstructured":"Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, et al. Survival outcomes and prognostic factors in mycosis fungoides\/S\u00c3\u00a9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28(31):4730\u20139.","journal-title":"J Clin Oncol"},{"issue":"32","key":"353_CR89","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","volume":"33","author":"JJ Scarisbrick","year":"2015","unstructured":"Scarisbrick JJ et al. Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sezary syndrome: effect of specific prognostic markers on survival and development of a prognostic model. J Clin Oncol. 2015;33(32):3766\u201373.","journal-title":"J Clin Oncol"},{"issue":"3","key":"353_CR90","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2013.03.036","volume":"69","author":"JY Li","year":"2013","unstructured":"Li JY et al. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides. J Am Acad Dermatol. 2013;69(3):366\u201374.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"353_CR91","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archdermatol.2008.46","volume":"144","author":"W Kempf","year":"2008","unstructured":"Kempf W et al. Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). Arch Dermatol. 2008;144(12):1609\u201317.","journal-title":"Arch Dermatol"},{"issue":"2","key":"353_CR92","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jaad.2010.05.041","volume":"65","author":"RA Abbott","year":"2011","unstructured":"Abbott RA, Sahni D, Robson A, Agar N, Whittaker S, et al. Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features. J Am Acad Dermatol. 2011;65(2):313\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"353_CR93","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0190-9622(97)70243-3","volume":"36","author":"HS Zackheim","year":"1997","unstructured":"Zackheim HS, McCalmont TH, Deanovic FW, Odom RB. Mycosis fungoides with onset before 20 years of age. J Am Acad Dermatol. 1997;36(4):557\u201362.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"353_CR94","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1610-0387.2007.06337.x","volume":"5","author":"C Assaf","year":"2007","unstructured":"Assaf C, Gellrich S, Steinhoff M, Nashan D, Weisse F, et al. Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG). J Dtsch Dermatol Ges. 2007;5(8):662\u20138.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"353_CR95","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1525-1470.2010.01129.x","volume":"27","author":"A Nanda","year":"2010","unstructured":"Nanda A, AlSaleh QA, Al-Ajmi H, Al-Sabah H, Elkashlan M, et al. Mycosis fungoides in Arab children and adolescents: a report of 36 patients from Kuwait. Pediatr Dermatol. 2010;27(6):607\u201313.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"353_CR96","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaad.2013.12.029","volume":"70","author":"E Hodak","year":"2014","unstructured":"Hodak E, Amitay-Laish I, Feinmesser M, Davidovici B, David M, et al. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement. J Am Acad Dermatol. 2014;70(6):993\u20131001.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"353_CR97","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/jid.2010.8","volume":"130","author":"E Laharanne","year":"2010","unstructured":"Laharanne E, Oumouhou N, Bonnet F, Carlotti M, Gentil C, et al. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes. J Invest Dermatol. 2010;130(6):1707\u201318.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"353_CR98","first-page":"225","volume":"68","author":"K Abdul Samad","year":"2002","unstructured":"Abdul Samad K, Prasanna MK, Akhar AP. Sezary syndrome\u2014without erythroderma. Indian J Dermatol Venereol Leprol. 2002;68(4):225\u20136.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"353_CR99","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/CCO.0000000000000161","volume":"27","author":"JA DeSimone","year":"2015","unstructured":"DeSimone JA, Sodha P, Ignatova D, Dummer R, Cozzio A, et al. Recent advances in primary cutaneous T-cell lymphoma. Curr Opin Oncol. 2015;27(2):128\u201333.","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"353_CR100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaad.2014.10.019","volume":"72","author":"M Desai","year":"2015","unstructured":"Desai M et al. Clinical characteristics, prognostic factors, and survival of 393 patients with mycosis fungoides and Sezary syndrome in the southeastern United States: a single-institution cohort. J Am Acad Dermatol. 2015;72(2):276\u201385.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 6","key":"353_CR101","doi-asserted-by":"crossref","first-page":"vi149","DOI":"10.1093\/annonc\/mdt242","volume":"24","author":"R Willemze","year":"2013","unstructured":"Willemze R et al. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi149\u201354.","journal-title":"Ann Oncol"},{"issue":"6","key":"353_CR102","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jaad.2011.07.012","volume":"66","author":"A Souza de","year":"2012","unstructured":"de Souza A et al. In search of prognostic indicators for lymphomatoid papulosis: a retrospective study of 123 patients. J Am Acad Dermatol. 2012;66(6):928\u201337.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"353_CR103","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/1097-0142(19921215)70:12<2951::AID-CNCR2820701236>3.0.CO;2-7","volume":"70","author":"HH Wang","year":"1992","unstructured":"Wang HH, Lach L, Kadin ME. Epidemiology of lymphomatoid papulosis. Cancer. 1992;70(12):2951\u20137.","journal-title":"Cancer"},{"issue":"18","key":"353_CR104","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","volume":"18","author":"R Talpur","year":"2012","unstructured":"Talpur R, Singh L, Daulat S, Liu P, Seyfer S, et al. Long-term outcomes of 1,263 patients with mycosis fungoides and S\u00e9zary syndrome from 1982 to 2009. Clin Cancer Res. 2012;18(18):5051\u201360.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"353_CR105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2015.09.013","volume":"74","author":"I Wieser","year":"2016","unstructured":"Wieser I, Oh CW, Talpur R, Duvic M. Lymphomatoid papulosis: treatment response and associated lymphomas in a study of 180 patients. J Am Acad Dermatol. 2016;74(1):59\u201367.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"353_CR106","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/jdv.13044","volume":"29","author":"W Kempf","year":"2015","unstructured":"Kempf W, Kazakov DV, Belousova IE, Mitteldorf C, Kerl K. Paediatric cutaneous lymphomas: a review and comparison with adult counterparts. J Eur Acad Dermatol Venereol. 2015;29(9):1696\u2013709.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"353_CR107","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clml.2015.11.010","volume":"16","author":"R Talpur","year":"2016","unstructured":"Talpur R et al. Retrospective analysis of prognostic factors in 187 cases of transformed mycosis fungoides. Clin Lymphoma Myeloma Leuk. 2016;16(1):49\u201356.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"353_CR108","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2230.2010.03900.x","volume":"36","author":"K Iqbal","year":"2011","unstructured":"Iqbal K, Bott J, Robson A, Post R, Morris S, et al. Nonerythrodermic S\u00e9zary syndrome. Clin Exp Dermatol. 2011;36(2):207\u20138.","journal-title":"Clin Exp Dermatol"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-016-0353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-016-0353-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-016-0353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T09:03:24Z","timestamp":1718960604000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-016-0353-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":108,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1007\/s11899-016-0353-y","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}